Update on FDA Advisory Committee vote on investigational medicine Ridaforolimus
20 March 2012 | By Merck
"Merck remains confident in the potential of the investigational agent ridaforolimus..."
List view / Grid view
20 March 2012 | By Merck
"Merck remains confident in the potential of the investigational agent ridaforolimus..."
20 March 2012 | By GlaxoSmithKline
“Treatment options for patients with advanced soft tissue sarcoma are limited..."